Cargando…
COVID-19 in a MS patient treated with ocrelizumab: does immunosuppression have a protective role?
BACKGROUND: Coronavirus disease 19 (COVID-19) is a novel disease entity that is spreading throughout the world. It has been speculated that patients with comorbidities and elderly patients could be at high risk for respiratory insufficiency and death. Immunosuppression could expose infected patients...
| Autores principales: | , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier B.V.
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7156942/ https://www.ncbi.nlm.nih.gov/pubmed/32315980 http://dx.doi.org/10.1016/j.msard.2020.102120 |